Hostname: page-component-77f85d65b8-2tv5m Total loading time: 0 Render date: 2026-03-28T18:01:10.764Z Has data issue: false hasContentIssue false
  • English
  • Français

Human papillomavirus and salivary gland neoplasia: a p16INK4 immunohistochemical and in situ hybridisation study

Published online by Cambridge University Press:  20 July 2015

M S Miah ,
S Majumdar ,
S White ,
M Robinson  and
N Kernohan
M S Miah*
Affiliation:
Department of ENT – Head and Neck Surgery, Ninewells Hospital and University of Dundee Medical School, Scotland
S Majumdar
Affiliation:
Department of ENT – Head and Neck Surgery, Ninewells Hospital and University of Dundee Medical School, Scotland
S White
Affiliation:
Department of Pathology, Ninewells Hospital and University of Dundee Medical School, Scotland
M Robinson
Affiliation:
Department of Oral Pathology, Centre for Oral Health Research, Freeman Hospital and University of Newcastle upon Tyne, UK
N Kernohan
Affiliation:
Department of Pathology, Ninewells Hospital and University of Dundee Medical School, Scotland
*
Address for correspondence: Mr M S Miah, Department of ENT – Head and Neck Surgery, Ninewells Hospital and University of Dundee Medical School, Dundee DD1 9SY, UK Fax: +44 1382 632816 E-mail: mohammedmiah@nhs.net
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

This study aimed to evaluate the association between human papillomavirus infection and salivary gland tumours in a Scottish cohort.

Methods:

Specimens from a range of salivary gland tumours operated on between 1997 and 2012 were studied. A tissue microarray constructed from tissue blocks was subjected to p16INK4 (cyclin-dependent kinase inhibitor 2A) immunohistochemistry and in situ hybridisation using probes specific for human papillomavirus, including types 16 and 18.

Results:

A total of 61 tumours (benign and malignant) were deemed suitable for the study. p16INK4 staining yielded three (4.9 per cent) positive samples: one small cell carcinoma, one squamous cell carcinoma and one poorly differentiated carcinoma. Human papillomavirus in situ hybridisation demonstrated a positive signal in the latter sample only (1.6 per cent).

Conclusion:

This study demonstrated a very low human papillomavirus detection rate in salivary gland tumours. It can therefore be concluded that human papillomavirus infection is unlikely to play a role in salivary gland neoplasia. Rare human papillomavirus positive cases should be carefully evaluated to exclude the possibility of a metastatic lesion.

Keywords

Salivary GlandsHuman PapillomavirusNeoplasms

Information

Type
Main Articles
Information
The Journal of Laryngology & Otology , Volume 129 , Issue 10 , October 2015 , pp. 1000 - 1003
Copyright
Copyright © JLO (1984) Limited 2015 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

Footnotes

Presented as an oral presentation at the ENT UK Annual Meeting 2014, 12 September 2014, London, UK

References

1Monk, BJ, Tewari, KS. The spectrum and clinical sequelae of human papillomavirus infection. Gynecol Oncol 2007;107:S6–S13CrossRefGoogle ScholarPubMed
2Shukla, S, Bharti, AC, Mahata, S, Hussain, S, Kumar, R, Hedau, S et al. Infection of human papillomaviruses in cancers of different human organ sites. Indian J Med Res 2009;130:222–33Google ScholarPubMed
3Syrjänen, K, Syrjänen, S, Lamberg, M, Pyrhonen, S, Nuutinen, J. Morphological and immunohistochemical evidence suggesting human papillomavirus (HPV) involvement in oral squamous cell carcinogenesis. Int J Oral Maxillofac Surg 1983;12:418–24Google ScholarPubMed
4Mehanna, H, Beech, T, Nicholson, T, El-Hariry, I, McConkey, C, Paleri, V et al. Prevalence of Human Papillomavirus in oropharyngeal and non-oropharyngeal head and neck cancer – systematic review and meta-analysis of trends by time and region. Head Neck 2013;35:747–55CrossRefGoogle Scholar
5Romanitan, M, Näsman, A, Ramqvist, T, Dahlstrand, H, Polykretis, L, Vogiatzis, P et al. Human papillomavirus frequency in oral and oropharyngeal cancer in Greece. Anticancer Res 2008;28:2077–80Google ScholarPubMed
6Hammarstedt, L, Lindquist, D, Dahlstrand, H, Romanitan, M, Dahlgren, L, Joneberg, J et al. Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int J Cancer 2006;119:2620–3CrossRefGoogle ScholarPubMed
7Castro, T, Bussoloti, F. Prevalence of human papillomavirus (HPV) in oral cavity and oropharynx. Braz J Otorhinolaryngol 2006;72:272–82CrossRefGoogle ScholarPubMed
8Szkaradkiewicz, A, Kruk-Zagajewska, A, Wal, M, Jopek, A, Wierzbicka, M, Kuch, A. Epstein-Barr virus and human papillomavirus infections and oropharyngeal squamous cell carcinomas. Clin Exp Med 2002;2:137–41CrossRefGoogle ScholarPubMed
9El-Mofty, S, Patil, S. Human papillomavirus (HPV)-related oropharyngeal nonkeratinizing squamous cell carcinoma: characterization of a distinct phenotype. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;101:339–45CrossRefGoogle ScholarPubMed
10Hobbs, C, Sterne, J, Bailey, M, Heyderman, R, Birchall, M, Thomas, S. Human papillomavirus and head and neck cancer: a systematic review and meta-analysis. Clin Otolaryngol 2006;31:259–66CrossRefGoogle ScholarPubMed
11Termine, N, Panzarella, V, Falaschini, S, Russo, A, Matranga, D, Lo Muzio, L et al. HPV in oral squamous cell carcinoma vs head and neck squamous cell carcinoma biopsies: a meta-analysis (1988–2007). Ann Oncol 2008;19:1681–90CrossRefGoogle ScholarPubMed
12Kreimer, A, Clifford, G, Boyle, P, Franceschi, S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 2005;14:467–75CrossRefGoogle ScholarPubMed
13Miller, C, Johnstone, B. Human papillomavirus as a risk factor for oral squamous cell carcinoma: a meta-analysis, 1982–1997. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;91:622–35CrossRefGoogle ScholarPubMed
14Dayyani, F, Etzel, C, Liu, M, Ho, C, Lippman, S, Tsao, A. Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC). Head Neck Oncol 2010;2:15CrossRefGoogle ScholarPubMed
15Stenner, M, Klussmann, JP. Current update on established and novel biomarkers in salivary gland carcinoma pathology and the molecular pathways involved. Eur Arch Otorhinolaryngol 2009;266:333–41CrossRefGoogle ScholarPubMed
16Hafed, L, Farag, H, Shaker, O, El-Rouby, D. Is human papilloma virus associated with salivary gland neoplasms? An in situ-hybridization study. Arch Oral Biol 2012;57:1194–9CrossRefGoogle Scholar
17Skálová, A, Kašpírková, J, Andrle, P, Hostička, L, Vaneček, T. Human papillomaviruses are not involved in the etiopathogenesis of salivary gland tumors [in Czech]. Cesk Patol 2013;49:72–5Google Scholar
18Jour, G, West, K, Ghali, V, Shank, D, Ephrem, G, Wenig, BM. Differential expression of p16(INK4A) and cyclin D1 in benign and malignant salivary gland tumors: a study of 44 cases. Head Neck Pathol 2013;7:224–31CrossRefGoogle ScholarPubMed
19Brunner, M, Koperek, O, Wrba, F, Erovic, BM, Heiduschka, G, Schoppper, C et al. HPV infection and p16 expression in carcinomas of the minor salivary glands. Eur Arch Otorhinolaryngol 2012;269:2265–9CrossRefGoogle ScholarPubMed
20Vageli, D, Sourvinos, G, Ioannou, M, Koukoulis, GK, Spandidos, DA. High-risk human papillomavirus (HPV) in parotid lesions. Int J Biol Markers 2007;22:239–44CrossRefGoogle ScholarPubMed
21Atula, T, Grénman, R, Klemi, P, Syrjänen, S. Human papillomavirus, Epstein-Barr virus, human herpesvirus 8 and human cytomegalovirus involvement in salivary gland tumours. Oral Oncol 1998;34:391–5CrossRefGoogle ScholarPubMed
22Descamps, G, Duray, A, Rodriguez, A, Chantrain, G, Depuydt, CE, Delvenne, P et al. Detection and quantification of human papillomavirus in benign and malignant parotid lesions. Anticancer Res 2012;32:3929–32Google ScholarPubMed
23Singhi, A, Westra, W. Comparison of human papillomavirus in situ hybridization and p16 immunohistochemistry in the detection of human papillomavirus-associated head and neck cancer based on a prospective clinical experience. Cancer 2010;116:2166–73CrossRefGoogle ScholarPubMed
24Oliveira, MC, Andrade, MC, Menezes, FS. Epidemiology of HPV in Head and Neck Cancer. In: Human Papillomavirus and Related Diseases – From Bench to Bedside – A Clinical Perspective. Vanden, Broeck D, ed. Rijeka, Croatia: InTech, 2012;197–220Google Scholar
25Anderson, CE, McLaren, KM, Rae, F, Sanderson, RJ, Cuschieri, KS. Human papilloma virus in squamous carcinoma of the head and neck: a study of cases in south east Scotland. J Clin Pathol 2007;60:439–41CrossRefGoogle ScholarPubMed